Showing posts from February, 2016

Time for the second opinion

Since being referred for a second opinion for Lewy Body Dementia in September,  I have been waiting to the results of tests to come through so we can get the answers.

It's taken some time to get this far, but as a second specialist has now been in touch about a follow up appointment for my balance/ "Parkinson" issues, and  we found out the some results had not been forwarded to the correct place.
This morning my wife spoke to a medical secretary about this, and we have now been given an appointment date for early next month.
I confess that I am getting very nervous about this, but I am hopeful that this can now be resolved and we can move in with our lives,
It may be that more tests may be required, but at least things are now moving.
I have never been sure that I had a form of dementia, but recognised that I do have memory , balance and tremor problems at times. 
This short term memory has caused a lot of problems, and it got to the stage where I refused to get involve…

Skin Test Project to Aid LBD Diagnosis

Skin Test Project to Aid LBD Diagnosis α-Synuclein biopsy project Background
Dementia with Lewy bodies (DLB) is the second most common type of neurodegenerative dementia after Alzheimer’s disease. It is associated with characteristic features such as the symptoms of Parkinson’s disease, visual hallucinations and fluctuating cognitive impairment. The diagnosis of DLB can be difficult. Currently there is a scan that helps to diagnose DLB, but it is negative in around 1 in 5 people who have DLB. In the earliest stages of the disease, this scan may be less useful. DLB and Parkinson’s disease (PD) are part of a group of illnesses called Lewy body disorders. These are cause by deposition of a protein called α-synuclein in the brain. α-synuclein is also found in other parts of the body, such as the nerves in the skin and gut. Identifying α-synuclein in areas outside the brain may help in the diagnosis of DLB and PD. Earlier diagnosis could be possible because α-synuclein may be present in these …

The Connection Between Dementia and Chronic Lung Disease

The Connection Between Dementia and Chronic Lung Disease 24 Mar 2015 | Under COPDLung DiseaseRelated Conditions | Posted by rmsadmin | 8 Comments Share this post:       Acknowledging the Dementia Epidemic Currently, we live in a society that constantly hears about the presence of Alzheimer’s disease and dementia. Between popular culture promoting films such as Still Alice and Away From Her and the increased effort to find a cure, people are finally beginning to care about these debilitating conditions. Just this past week at a World Health Organization (WHO) conference, a global action called for increased investment (over 100 million dollars) in promising research efforts for dementia. With the aging population, the WHO Director General said: “There is a tidal wave of dementia coming our way worldwide…we need to see greater investments in research to develop a cure, but also to improve the quality of life of people living with dementia and the support given to their caregivers.” In man…

COPD Linked to Cognitive Impairment

COPD Linked to Cognitive Impairment and Memory Loss Laurie Barclay, MD December 12, 2013 ·Add Other Topics ·Chronic Obstructive Pulmonary Disease (COPD) ·Chronic Obstructive Pulmonary Disease (COPD) and Emphysema in Emergency Medicine ·Emphysema Imaging Chronic obstructive pulmonary disease (COPD) was associated with increased odds of having mild cognitive impairment (MCI) and memory loss in a cross-sectional, population-based study. The study, published in the November issue of the Mayo Clinic Proceedings, also showed a dose–response relationship with COPD duration and increasing risk for cognitive problems. "In the absence of any effective therapy for dementia, the identification of risk factors for the development of MCI may hold the best promise for preventing or delaying the progression of early cognitive changes to clinical dementia," write Balwinder Singh, MD, from Mayo Clinic in Rochester, Minnesota, and colleagues. "Recent studies suggest that up to 77% of patients with…